Kayleigh Bhangdia on breast cancer GBD study 2023
About this episode
Kayleigh Bhangdia discusses the latest GBD breast cancer study data and its implications for global health.
Kayleigh Bhangdia discusses the latest GBD breast cancer study data, telling the audience about epidemiological trends, disease burden, and risk factors associated with breast cancer globally, regionally, and nationally for 204 countries from 1990 to 2023. Kayleigh sheds light on disparities in breast cancer burden across the globe and forecasts to 2050, and highlights the the most critical areas that future GBD studies should focus on to improve the accuracy, relevance, and impact of breast ...
More episodes of The Lancet Oncology in conversation with
- Fred Saad on quality of life in patients with metastatic hormone-sensitive prostate cancer
- James Nagarajah on [177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study
- Ali Landman on the European Congress of Radiology 2026
- Dylan Graetz and Erica Kaye on qualitative research in oncology
- Jesse Plascak and Marissa Baker on cancer mortality rates by occupation among US workers
- Andre Pfob and Peter Dubsky on The Lucerne Toolbox 3
Explore listener stats, chart rankings, contacts and more on the The Lancet Oncology in conversation with podcast page.